We serve Chemical Name:1-(2-nitroimidazol-1-yl)-3-(2,2,2-trifluoroethoxy)propan-2-ol CAS:21787-91-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(2-nitroimidazol-1-yl)-3-(2,2,2-trifluoroethoxy)propan-2-ol
CAS.NO:21787-91-7
Synonyms:1-[2-hydroxy-3-(2,2,2-trifluoroethoxy)propyl]-2-nitroimidazole;1-(2-nitro-imidazol-1-yl)-3-(2,2,2-trifluoro-ethoxy)-propan-2-ol;1-(2-Nitro-1-imidazoyl)-3-(2,2,2-trifluoroethoxy)-2-propanol;TF-MISO;Ro 07-2044
Molecular Formula:C8H10F3N3O4
Molecular Weight:269.17800
HS Code:2933290090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:449.1ºC at 760mmHg
Density:1.56g/cm3
Index of Refraction:1.516
PSA:93.10000
Exact Mass:269.06200
LogP:1.25430
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-[2-hydroxy-3-(2,2,2-trifluoroethoxy)propyl]-2-nitroimidazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ro 07-2044 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2-nitro-imidazol-1-yl)-3-(2,2,2-trifluoro-ethoxy)-propan-2-ol Use and application,1-(2-Nitro-1-imidazoyl)-3-(2,2,2-trifluoroethoxy)-2-propanol technical grade,usp/ep/jp grade.
Related News: But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 1-(2-nitroimidazol-1-yl)-3-(2,2,2-trifluoroethoxy)propan-2-ol manufacturer In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. 1-(2-nitroimidazol-1-yl)-3-(2,2,2-trifluoroethoxy)propan-2-ol supplier Both patients were being treated in isolation units at a Manila hospital. 1-(2-nitroimidazol-1-yl)-3-(2,2,2-trifluoroethoxy)propan-2-ol vendor But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 1-(2-nitroimidazol-1-yl)-3-(2,2,2-trifluoroethoxy)propan-2-ol factory Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions.
